Treatment of Buccal Mucosa Cancer at Stage I or Stage II

Early-stage buccal mucosa cancer — Stage I or Stage II — defines a specific clinical situation with distinct treatment considerations. The extent of disease at this stage shapes both the modality selected and the role of systemic therapy.

Clinical Scenario

This protocol applies to patients with buccal mucosa cancer at Stage I or Stage II. For early-stage disease, single-modality treatment is the established framework: either surgery or radiotherapy alone.

Treatment Approach (partial overview)

When concurrent chemo-radiation is the selected modality, cisplatin is the preferred chemotherapeutic agent.

Full regimen details, dosing schedules, and criteria for alternative agents are available in the complete structured protocol ↓

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.4103/0971-5851.138953

For early Stage (I or II), single modality treatment is used: Either surgery or RT alone.
When concurrent chemo-radiation is used, cisplatin is the preferred agent.

View source ↗